Related references
Note: Only part of the references are listed.Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd2O3 nanorods with dual-model imaging and targeted therapy of brain tumor
Weina Zhang et al.
CHINESE CHEMICAL LETTERS (2020)
Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy
Yuzhu Hu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Anti-Glioma Effect with Targeting Therapy Using Folate Modified Nano-Micelles Delivery Curcumin
Yihong He et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)
Ultrasound-Triggered Nanodroplets for Targeted Co-Delivery of Sorafenib/Doxorubicin for Hepatocellular Carcinoma Therapy
Tan Yang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
Mariam Abotaleb et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
Martin Reck et al.
LUNG CANCER (2018)
Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers
Tongtong Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor- B and the serine/threonine kinase Akt and is independent of tubulin polymerization (vol 280, pg 6301, 2005)
Smitha V. Bava et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
pH-Responsive supramolecular micelle based on host-guest interaction of poly(β-amino ester) derivatives and adamantyl-terminated poly(ethylene glycol) for cancer inhibition
Zhuting Yang et al.
CHINESE CHEMICAL LETTERS (2018)
Enhanced uptake and improved anti-tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer
Yuzhu Hu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer
Xiaoxiao Liu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
Jaime Prat
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Hugo E. R. Ford et al.
LANCET ONCOLOGY (2014)
Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells
Aditi Mathur et al.
PLOS ONE (2014)
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
Robert M. Wenham et al.
GYNECOLOGIC ONCOLOGY (2013)
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial
Athanassios Argiris et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Current development in nanoformulations of docetaxel
Qi Tan et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma
Changyang Gong et al.
NANOSCALE (2012)
Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer
Payam Zahedi et al.
MOLECULAR PHARMACEUTICS (2011)
The effects of mixed MPEG-PLA/Pluronic® copolymer micelles on the bioavailability and multidrug resistance of docetaxel
Chao-Feng Mu et al.
BIOMATERIALS (2010)
Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro
XiuLing Zheng et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin
Yi-Dong Yan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
Bharat B. Aggarwal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
Narayanan K. Narayanan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Curcumin and cancer: An old-age disease with an age-old solution
Preetha Anand et al.
CANCER LETTERS (2008)
Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism
Antonius E. van Herwaarden et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis
Marcia Cruz-Correa et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse
SP Valentine et al.
LIFE SCIENCES (2006)
Docetaxel for treatment of solid tumours: a systematic review of clinical data
A Montero et al.
LANCET ONCOLOGY (2005)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder
W Chearwae et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs
YC Dong et al.
BIOMATERIALS (2004)
First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer
GCE Stuart
GYNECOLOGIC ONCOLOGY (2003)
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer
G Aravantinos et al.
ANNALS OF ONCOLOGY (2003)
Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031
JS Woo et al.
PHARMACEUTICAL RESEARCH (2003)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
